Marc Gautier is an Oncology physician affiliated with Dartmouth–Hitchcock Medical Center. OpenAlex indexes 18 publications with 325 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Medical Center Dr
Section Of Hematology/ioncology
Lebanon, NH 037561000
Telephone
603-650-5529Registry record last updated 13 Jul 2011.
Clinical trials
- Low Dose Melphalan and Bortezomib for AML and High-Risk MDS
Sponsor: Dartmouth-Hitchcock Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
74.2%Thalidomide Analog25.1%Revlimid54%Pomalyst26%Lenalidomide19%Part D<11 patientsKinase inhibitor17%Jakafi26%Imbruvica23%Ibrance14%Tepmetko13%Imatinib Mesylate13%Calquence12%Part D<11 patients+ 5 more classes in this area
Dermatology
12.9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor12.9%Acyclovir100%Part D≥15 patientsMetabolism & gastrointestinal
4.7%Potassium supplement2.3%Potassium Chloride100%Part D<11 patientsCorticosteroid2.3%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Tanush Gupta, MD
Dartmouth–Hitchcock Medical Center
Jack Cronenwett, MD
Dartmouth–Hitchcock Medical Center
David Malenka, MD
Dartmouth–Hitchcock Medical Center
Robert Santulli, MD
Dartmouth–Hitchcock Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”